| HMS EUROPE® COMMENT RETARDER LE VIEILLISSEMENT DE L'HOMME |
1.
DEBLED G. The male climacteric, prime cause of sex involution. The tenth annual
international symposium on man and his environment in health and disease.
February 27 - March 1, 1992, Dallas.Texas.U.S.A.
2.
DEBLED G. The male climacteric, prime cause of aging. The tenth annual
international symposium on man and his environment in health and disease.
February 27 - March 1, 1992, Dallas.Texas.U.S.A.
3. DEBLED G. L'Andropause. Cause, conséquences et remèdes. Maloine,1988.
4. DEBLED G. Le traitement hormonal du vieillissement sexuel de l'homme.
Journal de médecine esthétique et de chirurgie dermatologique.
Vol
XXII- N° 85 : 7-16, 1995
5. DEBLED G. -L'Hyperoestrogénie Associée à la Dysectasie Fibreuse de l'Urètre Prostatique : Bulletins et Mémoires de la Société de Médecine de Paris, 7 : 199-204, 1980.
6. BAKER
H.W.G., BURGER H.G., O'CONNOR S., WANG C., MIROVICS A., COURT J., DUNLOP M.,
RENNIE G.C. - Changes in the
7.
PIRKE K.M., DOERR P. -Age related Changes in Free Plasma Testosterone,
Dihydrotestosterone and Estradiol.
Acta
Endocrinol., 80 : 171-178, 1975.
8.
PURIFOY F.E., KOOPMANS L.H., MAYES D.M. -Age Differences in Serum Androgen
Levels in Normal Adult Males :
Human
Biol., 53 : 499-511, 1981.
9. CULIG Z., HOBISCH A., HITTMAIR A., PETERZIEL H., CRONAUER M.V., BARTSCH G., CATO A.C.B., KLOCKER H : Androgen Receptor Structure and Function in Advanced Prostate Cancer. 5e Journée scientifique de l'Association pour la Recherche sur les TUMEURS dela Prostate (A.R.T.P.). 6 décembre 1996.
10. ROBEL P. Mode d'Action des Androgènes : Les Androgènes.
Rapports présentés a la XVe réunion des endocrinologistes de langue française:
20-38 . Athènes, 6-8 septembre 1979. Masson. Paris. New York. Barcelone.
Milan,1979.
11.
BREUER C.B. AND FLORINI J.R. Amino Acid Incorporation into Protein by Cell-free
Systems from Rat Skeletal Muscle IV- Effects of Animal Age, Androgens and
Anabolic Agents on Activity of Muscle Ribosomes : Biochemistry, 4 : 1544-1550,
1965.
12.
FLORINI J.R. Effects of Testosterone on Qualitative Pattern of Protein Synthesis
in Skeletal Muscle :
Biochemistry,
9 : 909-912, 1970.
13.
BRESLOFF P., FOX P., SIM A. AND VAN DER VIES J. The Effect of Nandrolone
Phenylpropionate on C14-Leucine Incorporation into Muscle Protein in the Rat and
Rabbit in Vivo :
14.
BURESOVA M. and GUTMANN E. Effect of Testosterone on Protein Synthesis and
Contractility of the Levator Ani Muscle of the Rat : J. Endocr., 50 : 643-651,
1971.
15.
POWERS M.L. AND FLORINI J.R. A Direct Effect of Testosterone on Muscle Cells in
Tissue Culture. Endocrinology. 97 : 1043-1047, 1975.
16.
PELLEGRINI G. L'Azione Antidiabetica degli Ormoni Sessuali Maschili nel quadro
della Fisiopatologia del Diabete. Minerva Medica, 27 : 1-9, 1947.
17.
LITTLE K. Interaction between catabolic and anabolic steroids. Curr. Ther. Res.
12 : 658-676, 1970.
18.
ALOIA J.F. AND FIELD R.A. The effects of androgens and related substances on
carbohydrate metabolism, lipid metabolism and diabetes mellitus. Pharmac. Ther.
1 : 241-257, 1976.
19. ANDO
S., RUBENS R. AND ROTTIERS R. Androgen Plasma Levels in Male Diabetics. J.
Endocrinol. Invest., 7 : 21-24, 1984.
20.
MOELLER J. Cholesterol : 27 Springer-Verlag
Berlin Heidelberg
New York London
Paris Tokyo 1987.
21.
HARRIS M. AND ENTMACHER PS. Mortality from Diabetes, in Diabetes in America :
NIH Publication, 85 : 1468 U.S.
Government Printing Office1985.
22. WHO
Study Group -Diabetes Mellitus : World Health Organization Technical Report
Series 727 GENEVA 1985.
23.
LIPID RESEARCH PROGRAM -The Lipid Research Clinics Population Studies Data Book
-NIH Publication No 80 : 1527, vol 1 BETHESDA,
1980.
24.
CREFF A.F. AND HERCHBERG A.D. Obésité, p.126. Masson. 1988
25.
Marks H.H. -Influence of Obesity on Morbidity and Mortality : Bull. N.Y. Acad. Sc., 36 : 296, 1960.
26. RAISON J. Obésité Androïde : le Mécanisme de la Surmortalité Cardio-Vasculaire est Expliqué :
Le Quotidien du médecin, 4632 :14-15, 1990.
27.
GLASS A.R., SWERDLOFF R.S., BRAY G.A., DAHMS W.T., ATKINSON R.L. Low Serum
Testosterone and Sex-Hormone-Binding-Globulin in Massively Obese Men :
28.
ZUMOFF B., STRAIN G.W., MILLER L.K., ROSNER W., SENIE R., SERES D.S. AND
ROSENFELD R.S. Plasma Free and
Non-Sex-Binding-Globulin-Bound
Testosterone Are Decreased in Obese Men in Proportion to their Degree of Obesity
:
J. Clin. Endocrinol. Metabol., 71,4 : 929-931, 1990.
29. PLAS F. -Variations de la Fonction Androgénique au
cour des Efforts Prolongés : Bull.
Acad.
Nat. Méd., 162,6 : 494-499, 1978.
30.
NATIONAL CENTER FOR HEALTH STATISTICS .Vital Statistics Report, Final Mortality
Statistics, 1982.
31.
FEARNEY G.R. AND CHAKRABARTI R. Increase of Blood Fibrinolytic Activity by
Testosterone :
The
Lancet, July 21 : 128-132, 1962.
32.
BONITHON-KOPP C., SCARABIN P.-Y., BARA L., CASTANIER M., JAQUESON A. AND ROGER
M. Relationship between Sex Hormones and Haemostatic Factors in Healthy
Middle-Aged Men : Artheriosclerosis, 71: 71-76, 1988.
33.
NAJEAN Y. and coll. Long Term Follow-up in Patients with Aplastic Anemia. A
study of 137 Androgen-Treated Patients Surviving more than Two Years :
Am. J. Med., 71 : 543-551, 1981.
34. HARRISON T.R. Principes de Médecine Interne. :
Appendice A 10. Tableau A-XII. Médecine-Sciences Flammarion, 1989.
Paris.
35. BLASIUS
R., KAFER K., SEITZ W. - Untersuchungen über die Wirkung von Testosteron auf
die Contractilen Strukturproteine des Herzens.
Klin.
Woch., 34, 11/12, 324, 1956.
36.
KRIEG M., SMITH K. and BARTSCH W. -Demonstration of a Specific Androgen Receptor
in Rat Heart Muscle : Relationship between Binding Metabolism and Tissue Levels
of Androgens : Endocrinology, 103 : 1686-1694, 1978.
37.
KRIEG M., SMITH K. and ELVERS B. -Androgen Receptor Translocation from Cytosol
of Rat Heart Muscle, Bulbocavernosus Levator Ani Muscle and Prostate into heart
Muscle Nuclei :
38.
BREIER CH., DREXEL H., LISCH H.-J., MÜHLBERGER V., HEROLD M. AND KNAPP E.
Essential Role of Post-Heparin Lipoprotein Lipase Activity and of Plasma
Testosterone in Coronary Artery Disease : The Lancet, June 1 : 1242-1244, 1985.
39.
CHUTE CH., G., BARON J.A., PLYMATE S.R., KIEL D.P., PAVIA A.T., LOZNER E.C., O'KEEFE
TH. AND MAC DONALD G.J. Sex Hormones and Coronary Artery Disease.
AM.
J. Med., 83 : 853-859, 1987.
40.
PHILLIPS G.B. Sex Hormones, Risk Factors and Cardiovascular Disease : Am. J. Med.,
65 : 7-11, 1978.
41.
ENTRICAN J.H., BEACH C., CARROL D., KENMORE A.C.F., KLOPPER A., MACKIE M. AND
DOUGLAS A.S. Raised Plasma Oestradiol and Estrone Levels in Young Survivors of
Myocardial Infarction :
42.
MENDOZA S.G., ZERA A., CARRASCO H., COLMENARES O., RANGEL A., GARTSIDE P.S. AND
KASHYAP M.L. Estradiol, Testosterone, Apolipoproteins, Lipoprotein Cholesterol
and Lipolityc Enzymes in Men with Premature Myocardial Infarction and
Angiographically Asseced Coronary Occlusion : Artery, 12 : 1-23, 1983.
43.
BARTH J.D., JANSEN H., HUGENHOLTZ P.G. AND BIRKENHÄGER J.C. Post-Heparin
Lipases, Lipids and Related Hormones in Men Undergoing Coronary Arteriography to
Assess Atherosclerosis :
44.
LESSER M.A. Testosterone propionate therapy in one hundred cases of
angina pectoris : J. Clin. Endocrinol., 6 : 549-557, 1946.
45.
MOLLER J. AND EINFELDT. Testosterone Treatment of Cardiovascular Diseases
Springer-Verlag. Berlin. Heidelberg. New York. Tokyo, 1984.
46.
JAFFE M.D. Effect of Testosterone Cypionate on Postexercise ST Segment
Depression : British Heart Journal.
39
: 1217-1222, 1977.
47. GEISTHÖVEL
W., PERSCHKE B., VON ZUR MÜHLEN A.
Das Verkalter
von Testosteron, Freier Testosteronfraktion LH und FSH im Plasma von Männern Wärend
der Frühphase des Akuten
Myocardinfarktes : Z. Cardiol., 68 : 776-783, 1979.
48.
SWARTZ C.M. AND YOUNG M.A. Low Serum Testosterone and Myocardial Infarction in
Geriatric Male Inpatients :
JACG :
35 : 39-44, 1987.
49.
SIMON DOMINIQUE, CHARLES MARIE-ALINE, NAHOUL KHALIL, ORSSAUD GENEVIEVE,
KREMSKI JACQUELINE, HULLY VÉRONIQUE, JOUBERT EVELYNE, PAPOZ LAURE AND ESCHWEGE
EVELINE. The Telecom study. Unit
U-21 of INSERM of France :
Association
between plasma total testoterone and cardiovascular risk factors in healthy
adult men : The Journal of Clinical Endocrinology and Metabolism Vol 82, N° 2,
p. : 682- 685, 1997.
50.
CARRUTHERS M. Danish Experiences in the Treatment of Advanced Circulatory
Disease with Anabolic Steroids-Bullitin E.O.C.C.D. 6, 1980.
51.
SHILLINGFORD J.P., JOPLIN C.F., JAMIESON C.W. AND RUBENS R. Visit to Dr.
Moeller's Clinic. Bullitin E.O.C.C.D., 6, 1980.
52.
YARNELL J. Visit to Prof. Moeller's Clinic, Copenhagen- Bullitin. E.O.C.C.D., 6,
1980.
53.
ZETTERQUIST S. The effect of Active Training on the Nutitive Blood Flow in
Exercising Ischemic Legs :
J. Clin. Lab. Invest., 25 : 101-111, 197O.
54. ROBERT L. Les Horloges Biologiques. Nouvelle Bibliothèque Scientifique Flammarion, 1989.
55.
SOBEL H. AND MARMORSTON J. Hormonal Influences Upon Connective Tissue Changes of
Aging, in : PINCUS G (ed) Recent Progress in Hormone Research, vol 14. Academic
New York 1958.
56. BARAN D.T., M.A. BERGFELD,S.T. TEITELBAUM AND L.V. AVIOLI. Effect of testosterone therapy on bone formation in an osteoporotic hypogonadal male. Calcif. Tiss. Res. 2§ : 103-106, 1978.
57. DELMAS P. ET MEUNIER P.J. L'Ostéoporose au cours du Syndrome de Klinefelter.
La Nouvelle Presse Médicale, 10 : 687-690, 1981.
58. MILHAUD G. Mécanisme d' Action de la Calcitonine au Niveau de la Matrice Calcifiable, in : L. Robert et H. Greiling Eds. Pharmacologie Cellulaire et Moléculaire des Maladies du Tissu
Conjonctif :
227-239. Boehringer. Ingelheim. Mannheim. Reims, 1983.
59.
FORESTA C., BURNARDO B., RUZZA G. et al. Lower Calcitonin Levels in Young
Hypogonadic Men with Osteoporosis :
Horm. Metab. Res., 15 : 206, 1983.
60.
SCHUURS A.H.W.M. and VERHEUL H.A.M. -Effects of Gender and Sex Steroids on the
Immune Response :
J. Steroid
Biochem., 35 ; 2 : 157-172, 1990
61.
AHMED S.A., PENHALE W.J. and TALAL N. -Sex Hormones, Immune Responses, and
Autoimmune Diseases :
AJP
-121, 3 : 531- 551, 1985.
62.
SASSON S. and MAYER M. -Antiglucocorticoid Activity of Androgens in Rat Thymus
Lymphocytes :
Endocrinology,
108 : 760-766, 1981.
63.
PERSKY H., SMITH K.D. AND BASU G.K. Relation of Psychologic Measures of
Aggression and Hostility to Testosterone Production in Man : Psychosomatic
Medecine, 33 ; 3 : 265-277, 1971.
64. EHRENKRANZ J., BLISS E. AND SHEARD M.H. Plasma Testosterone : Correlation with Aggressive Behavior and Social Dominance in Man. Psychosomatic Medecine, 36 ; 6 : 469-475, 1974.
65. de LIGNIERES ET MAUVAIS-JARVIS. Endocrinologie de la Dépression. Rôle du Cortisol et des Hormones Sexuelles :
Ann.
Biol. Clin., 37 : 49-57, 1979.
66.
MIGEON C.J., KELLER A.R., LAWRENCE B., SHEPARD T.H., Dehydroepiandrosterone and
androsterone levels in human plasma. Effect of age and sex, day-to-day and
diurnal variations, J. Clin. Endocrinol. Metab., 1957, 17 : 1051-62.
67.
ORENTREICH N., BRIND J.L., VOGELMAN J.H., Age changes and sex differences in
serum dehydroepiandrosterone sulfate concentrations throughout adulthood, J.
Clin. Endocrinol. Metab., 1984, 59 : 551-5.
68.
ORENTREICH N., BRIND J.L., VOGELMAN J.H., ANDRES
R., BALDWIN H., Long term longitudinal measurements of plasma
dehydroepiandrosterone sulfate in normal men, J. Clin. Endocrinol. Metab.,1992,
1002-4.
69.
KALIMI MOHAMMED and REGELSON
WILLIAM, The Biologic Role of Dehydrepiandrosterone (DHEA), Walter de Gruyter.
Berlin, New York,1990.
70. YOUNG J., COUZINET B., NAHOUL K., BAULIEU EE., et CHAISON G. Service d'Encrinologie et des Maladies de la Reproduction, Hôpital Bicêtre, 94275 Le Kremlin Bicêtre, INSERM U33 et IFR21, 94276 Le Kremlin Bicêtre Cedex France.